Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease

American Journal of Cardiology

Volumn 113, Issue 3, 2014, Pages 434-440

  Tuñón, José ^a,b,c   Blanco Colio, Luis ^b   Cristóbal, Carmen ^d,e   Tarín, Nieves ^f   Higueras, Javier ^g   Huelmos, Ana ^h   Alonso, Joaquín ^d,e   Egido, Jesús ^b,c,i   Asensio, Dolores ^a   Lorenzo, Óscar ^b,c   Mahíllo Fernández, Ignacio ^a   Rodríguez Artalejo, Fernando ^j   Farré, Jerónimo ^a,c   Martín Ventura, José Luis ^b,c   López Bescós, Lorenzo ^e  

^a 28400 Madrid   (Spain)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

^e UNIVERSIDAD REY JUAN CARLOS   (Spain)

^f HOSPITAL DE MÓSTOLES   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

ⁱ INSTITUTO DE SALUD CARLOS III   (Spain)

^j AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GALECTIN 3; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITRIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSIENT ISCHEMIC ATTACK;

AGED; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GALECTIN 3; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; STROKE; SURVIVAL RATE;

EID: 84892606192     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.10.012     Document Type: Article

References (24)

1. L. Gu, Y. Okada, S.K. Clinton, C. Gerard, G.K. Sukhova, P. Libby, and B.J. Rollins Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice Mol Cell 2 1998 275 281
2. J. Gosling, S. Slaymaker, L. Gu, S. Tseng, C.H. Zlot, S.G. Young, B.J. Rollins, and I.F. Charo MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B J Clin Invest 103 1999 773 778
3. L.M. Blanco-Colio, J.L. Martín-Ventura, B. Muñóz- García, J. Orbe, J.A. Páramo, J.B. Michel, A. Ortiz, O. Meilhac, and J. Egido Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis Arterioscler Thromb Vasc Biol 27 2007 916 922
4. D.J. Lok, P. Van Der Meer, P.W. de la Porte, E. Lipsic, J. Van Wijngaarden, H.L. Hillege, and D.J. van Veldhuisen Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study Clin Res Cardiol 99 2010 323 328
5. J. Dumic, S. Dabelic, and M. Flögel Galectin-3: an open-ended story Biochim Biophys Acta 1760 2006 616 635
6. P. Ramos-Mozo, J. Madrigal-Matute, M. Vega de Ceniga, L.M. Blanco-Colio, O. Meilhac, L. Feldman, J.B. Michel, P. Clancy, J. Golledge, P.E. Norman, J. Egido, and J.L. Martin-Ventura Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm Atherosclerosis 220 2012 552 556
7. S.S. Soni, C. Ronco, N. Katz, and D.N. Cruz Early diagnosis of acute kidney injury: the promise of novel biomarkers Blood Purif 28 2009 165 174
8. A. Yndestad, L. Landrø, T. Ueland, C.P. Dahl, T.H. Flo, L.E. Vinge, T. Espevik, S.S. Frøland, C. Husberg, G. Christensen, K. Dickstein, J. Kjekshus, E. Øie, L. Gullestad, and P. Aukrust Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure Eur Heart J 30 2009 1229 1236
9. A.S. Maisel, P. Krishnaswamy, R.M. Nowak, J. McCord, J.E. Hollander, P. Duc, T. Omland, A.B. Storrow, W.T. Abraham, A.H. Wu, P. Clopton, P.G. Steg, A. Westheim, C.W. Knudsen, A. Perez, R. Kazanegra, H.C. Herrmann, P.A. McCullough Breathing Not Properly Multinational Study Investigators Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
10. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
11. M. Hernández-Presa, C. Bustos, M. Ortego, J. Tuñón, G. Renedo, M. Ruiz-Ortega, and J. Egido Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis Circulation 95 1997 1532 1541
12. C. Bustos, M.A. Hernández-Presa, M. Ortego, J. Tuñón, L. Ortega, F. Pérez, C. Díaz, G. Hernández, and J. Egido HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis J Am Coll Cardiol 32 1998 2057 2064
13. A.D. Schecter, B.J. Rollins, Y.J. Zhang, I.F. Charo, J.T. Fallon, M. Rossikhina, P.L. Giesen, Y. Nemerson, and M.B. Taubman Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells J Biol Chem 272 1997 28568 28573
14. J.A. de Lemos, D.A. Morrow, M.S. Sabatine, S.A. Murphy, C.M. Gibson, E.M. Antman, C.H. McCabe, C.P. Cannon, and E. Braunwald Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes Circulation 107 2003 690 695
15. C.P. Cannon, C.H. McCabe, R.G. Wilcox, A. Langer, A. Caspi, P. Berink, J. Lopez-Sendon, J. Toman, A. Charlesworth, R.J. Anders, J.C. Alexander, A. Skene, and E. Braunwald Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial Circulation 102 2000 149 156
16. J.A. de Lemos, D.A. Morrow, M.A. Blazing, P. Jarolim, S.D. Wiviott, M.S. Sabatine, R.M. Califf, and E. Braunwald Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial J Am Coll Cardiol 50 2007 2117 2124
17. K. Fox, M.A. Garcia, D. Ardissino, P Buszman, P.G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, J. Lopez-Sendon, J. Marco, J. Morais, J. Pepper, U. Sechtem, M. Simoons, K. Thygesen, S.G. Priori, J.J. Blanc, A. Budaj, J. Camm, V. Dean, J. Deckers, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J. Tamargo, and J.L. Zamorano Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur Heart J 27 2006 1341 1381
18. E. Di Angelantonio, R. Chowdhury, N. Sarwar, K.K. Ray, R. Gobin, D. Saleheen, A. Thompson, V. Gudnason, N. Sattar, and J. Danesh B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies Circulation 120 2009 2177 2187
19. J.N. Cohn, R. Ferrari, and N. Sharpe Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling J Am Coll Cardiol 35 2000 569 582
20. N. Lopez-Andrès, P. Rossignol, W. Iraqi, R. Fay, J. Nuée, S. Ghio, J.G. Cleland, F. Zannad, and P. Lacolley Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial Eur J Heart Fail 14 2012 74 81
21. E.W. Grandin, P. Jarolim, S.A. Murphy, L. Ritterova, C.P. Cannon, E. Braunwald, and D.A. Morrow Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22 Clin Chem 58 2012 267 273
22. L. Gullestad, T. Ueland, J. Kjekshus, S.H. Nymo, J. Hulthe, P. Muntendam, J.J. McMurray, J. Wikstrand, and P. Aukrust The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) Am Heart J 164 2012 878 883
23. J. Kjekshus, E. Apetrei, V. Barrios, M. Böhm, J.G. Cleland, J.H. Cornel, P. Dunselman, C. Fonseca, A. Goudev, P. Grande, L. Gullestad, A. Hjalmarson, J. Hradec, A. Jánosi, G. Kamenský, M. Komajda, J. Korewicki, T. Kuusi, F. Mach, V. Mareev, J.J. McMurray, N. Ranjith, M. Schaufelberger, J. Vanhaecke, D.J. van Veldhuisen, F. Waagstein, H. Wedel, J. Wikstrand CORONA Group Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261
24. L. Gullestad, T. Ueland, J. Kjekshus, S.H. Nymo, J. Hulthe, P. Muntendam, A. Adourian, M. Böhm, D.J. van Veldhuisen, M. Komajda, J.G. Cleland, J. Wikstrand, J.J. McMurray, P. Aukrust, and CORONA Study Group Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) Eur Heart J 33 2012 2290 2996